MOLECULAR-STRUCTURE ANALYSIS OF THE PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE TYPE-I RECEPTOR FROM PIG BRAIN

被引:12
|
作者
CAO, YJ [1 ]
GIMPL, G [1 ]
FAHRENHOLZ, F [1 ]
机构
[1] MAX PLANCK INST BIOPHYS,D-60596 FRANKFURT,GERMANY
来源
关键词
PACAP RECEPTOR; PIG BRAIN; SOLUBILIZATION; DEGLYCOSYLATION; DESIALYLATION; SULFHYDRYL GROUP;
D O I
10.1016/0167-4889(94)90051-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In pig brain a type I receptor for pituitary adenylate cyclase activating polypeptide (PACAP) has been identified and structurally characterized. Scatchard analysis of the equilibrium binding data indicates a single class of binding sites with K, of 0.50 nM and B-max of 2.52 pmol/mg. The receptors could be efficiently solubilized with 3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy- 1-propanesulfonate (Chapso) without altering their ligand binding parameters (K-d = 0.60 nM; B-max = 2.46 pmol/mg). In both preparations the ligand receptor complex was identified as a 68 kDa polypeptide by affinity crosslinking with I-125-PACAP-27 and disuccinimidyl suberate. Employment of nonreducing conditions decreased the electrophoretic mobility of the complex to a 60 kDa species suggesting that the native PACAP receptor exists in a compact conformation stabilized by intramolecular disulfide bridges. Disulfide bonds are also important for the ligand binding activity of the PACAP receptor since pretreatment of the membranes with dithiothreitol led to complete inhibition of PACAP binding and to 61% dissociation of the ligand-receptor complex. Among different sulfhydryl selective reagents tested, p-chloromercuriphenylsulfonic acid was found to inhibit PACAP binding to its receptor in a dose-dependent fashion (IC50 = 0.5 mM) suggesting that one or more sulfhydryl groups are located close to the ligand binding domain of the receptor. Desialylation of the affinity-labeled PACAP receptor with neuraminidase revealed a 61 kDa protein, whereas deglycosylation with N-glycosidase F decreased the M(r) to 52000. Chromatography on a series of lectin agaroses showed the highest affinity for wheat germ agglutinin (WGA). WGA was also effective in dose-dependent inhibition of PACAP binding activity. Our results characterize the pig PACAP receptor as a tri- or tetraantennary non- or low fucosylated complex type glycoprotein with a protein core of about 49 kDa containing several terminal sialyl residues.
引用
收藏
页码:432 / 440
页数:9
相关论文
共 50 条
  • [21] Tracing the Origins of the Pituitary Adenylate-Cyclase Activating Polypeptide (PACAP)
    Cardoso, Joao C. R.
    Garcia, Manuel G.
    Power, Deborah M.
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [22] Production and characterization of monoclonal antibodies to pituitary adenylate cyclase activating polypeptide type I receptor
    Zvirblienë, A
    Zvirblis, G
    Cao, YJ
    Fahrenholz, F
    HYBRIDOMA, 1999, 18 (04): : 335 - 342
  • [23] Presence of Pituitary Adenylate Cyclase Activating Polypeptide and Its Type I Receptor in the Rat Kidney
    Brubel, R.
    Horvath, G.
    Reglodi, D.
    Lubics, A.
    Tamas, A.
    Kiss, P.
    Laszlo, E.
    Nemeth, J.
    Mark, L.
    Szakaly, P.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (04) : 1297 - 1299
  • [24] Distribution of pituitary adenylate cyclase activating polypeptide type I receptor in the nervous system of Oligochaeta
    Lubics, A.
    Pollak, E.
    Boros, A.
    Tamas, A.
    Lengvari, I.
    Reglodi, D.
    Molnar, L.
    NEUROPEPTIDES, 2008, 42 (04) : 498 - 499
  • [25] EXPRESSION OF PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE AND RECEPTORS IN HUMAN BRAIN-TUMORS
    VERTONGEN, P
    DHAENS, J
    MICHOTTE, A
    VELKENIERS, B
    VANRAMPELBERGH, J
    SVOBODA, M
    ROBBERECHT, P
    PEPTIDES, 1995, 16 (04) : 713 - 719
  • [26] DEVELOPMENTAL-CHANGES OF PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) AND ITS RECEPTOR IN THE RAT-BRAIN
    TATSUNO, I
    SOMOGYVARIVIGH, A
    ARIMURA, A
    PEPTIDES, 1994, 15 (01) : 55 - 60
  • [27] MOLECULAR-CLONING AND EXPRESSION OF A CDNA-ENCODING A RECEPTOR FOR PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP)
    MORROW, JA
    LUTZ, EM
    WEST, KM
    FINK, G
    HARMAR, AJ
    FEBS LETTERS, 1993, 329 (1-2) : 99 - 105
  • [28] PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP)-LIKE IMMUNOREACTIVITY IN PHEOCHROMOCYTOMAS
    TAKAHASHI, K
    TOTSUNE, K
    MURAKAMI, O
    SONE, M
    ITOI, K
    MIURA, Y
    MOURI, T
    PEPTIDES, 1993, 14 (02) : 365 - 369
  • [29] ANORECTIC AND NEUROCHEMICAL EFFECTS OF PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE IN RATS
    CHANCE, WT
    THOMPSON, H
    THOMAS, I
    FISCHER, JE
    PEPTIDES, 1995, 16 (08) : 1511 - 1516
  • [30] Homology modeling and molecular docking of human pituitary adenylate cyclase-activating polypeptide I receptor
    Wu, Lusheng
    Guang, Wenhua
    Chen, Xiaojia
    Hong, An
    MOLECULAR MEDICINE REPORTS, 2014, 10 (04) : 1691 - 1696